Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Pressure Biosciences (PBIO)

Pressure Biosciences (PBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Pressure Biosciences 440 Neponset Street Unit 10B CANTON MA 02021 USA

www.pressurebiosciences.com Employees: 16 P: 508-230-1828

Description:

Pressure BioSciences, Inc is a company focused on the development of a novel technology called Pressure Cycling Technology (PCT). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (35,000 psi and greater) to control bio- molecular interactions. Pressure BioSciences holds US and foreign patents covering multiple applications of PCT in the life sciences field, including in such areas as genomic and proteomic sample preparation, pathogen inactivation, control of enzymes, immunodiagnostics, and protein purification.

Key Statistics

Overview:

Market Capitalization, $K 164
Enterprise Value, $K 22,844
Shares Outstanding, K 40,967
Annual Sales, $ 1,980 K
Annual Net Income, $ -29,310 K
Last Quarter Sales, $ 350 K
Last Quarter Net Income, $ -8,070 K
EBIT, $ -7,340 K
EBITDA, $ -4,720 K
60-Month Beta -0.14
% of Insider Shareholders 10.80%
% of Institutional Shareholders 0.02%
Float, K 36,543
% Float 89.20%
Short Volume Ratio 0.54

Growth:

1-Year Return -98.96%
3-Year Return -99.83%
5-Year Return -99.76%
5-Year Revenue Growth -19.51%
5-Year Earnings Growth 90.15%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.22 on 09/06/24
Next Earnings Date 11/25/24 [--]
Earnings Per Share ttm -1.38
EPS Growth vs. Prev Qtr 26.67%
EPS Growth vs. Prev Year 52.17%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-30 on 06/05/17

PBIO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -1,480.30%
Debt/Equity -0.70
Price/Sales 0.05
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -1.13
Interest Coverage -0.88
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar